Skip to content

Clinical trials

Phase 2 COVID-19 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2 Clear all

871 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20183
20192
2020447
2021230
202295
202358
202418
202513
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed405
Unknown status174
Terminated166
Withdrawn83
Recruiting18
Active, not recruiting15
Not yet recruiting5
Suspended3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sorrento Therapeutics, Inc.13
National Institute of Allergy and Infectious Diseases (NIAID)11
Sinocelltech Ltd.10
Assistance Publique - Hôpitaux de Paris8
Washington University School of Medicine8
NYU Langone Health7
Pfizer7
The University of Hong Kong7
Health Institutes of Turkey6
Johns Hopkins University6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19871
Coronavirus Infections149
Respiratory Distress Syndrome45
Pneumonia44
Severe Acute Respiratory Syndrome44
Cytokine Release Syndrome22
Pneumonia, Viral21
Post-Acute COVID-19 Syndrome21
Respiratory Insufficiency19
Virus Diseases18

Trials

Showing 76 to 100 of 871. Each trial links to its page on Pharma Observatory.

771 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.